Skip to content
2000
Volume 27, Issue 1
  • ISSN: 1389-4501
  • E-ISSN: 1873-5592

Abstract

Cancer is a significant human health concern due to its increasing mortality rate and profound impact on public health and healthcare systems. The cytotoxic, antiproliferative, immunosuppressive, and apoptogenic properties of scorpion venom proteins and peptides have been observed in various cancer cell lines. Therefore, the purpose of this study was to investigate the potential use of proteins derived from scorpion venom in cancer treatment. In this study, the effects of different scorpion venoms on transmembrane channels, the inhibition of angiogenesis, the inhibition of invasion and metastasis, the inhibition of proliferation, and the induction of apoptosis were investigated, as were their clinical applications in the treatment of hepatocellular carcinoma and breast, cervical, prostate, colorectal, and melanoma cancers. The results showed that various scorpion venoms can suppress cell growth, stimulate apoptosis, reduce tumor size, and enhance the immune response, thereby serving as alternative drugs for treating various types of cancers and their metastasis. This review suggests a positive association between scorpion venom (SV) proteins and the treatment of these cancers. Future research should focus on understanding the underlying mechanisms, identifying biomarkers to predict response, and exploring potential combination therapies to increase the efficacy of scorpion venom proteins in cancer treatment.

© 2026 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cdt/10.2174/0113894501396738250904071722
2025-09-16
2026-02-26

  • From This Site

    /content/journals/cdt/10.2174/0113894501396738250904071722
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. SaraswatI. GoelA. Therapeutic modulation of the microbiome in oncology: Current trends and future directions.Curr. Pharm. Biotechnol.202526568069910.2174/011389201035360024110913244139543873
     [Google Scholar]
  2. SungH. FerlayJ. SiegelR.L. LaversanneM. SoerjomataramI. JemalA. BrayF. Global cancer statistics 2020: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J. Clin.202171320924910.3322/caac.2166033538338
     [Google Scholar]
  3. TangH. LiuW. HuangK. Stereotactic ablative radiotherapy for inoperable T1-2N0M0 small-cell lung cancer.Thorac. Cancer20221371100110110.1111/1759‑7714.1435535178871
     [Google Scholar]
  4. DebelaD.T. MuzazuS.G.Y. HeraroK.D. NdalamaM.T. MeseleB.W. HaileD.C. KituiS.K. ManyazewalT. New approaches and procedures for cancer treatment: Current perspectives.SAGE Open Med.2021910.1177/2050312121103436634408877
     [Google Scholar]
  5. UzairB. Bint-e-IrshadS. KhanB.A. AzadB. MahmoodT. RehmanM.U. BragaV.A. Scorpion venom peptides as a potential source for human drug candidates.Protein Pept. Lett.201825770270810.2174/092986652566618061411430729921194
     [Google Scholar]
  6. Abdel-RahmanM.A. HarrisonP.L. StrongP.N. Snapshots of scorpion venomics.J. Arid Environ.201511217017610.1016/j.jaridenv.2014.01.007
     [Google Scholar]
  7. GhadiriN JavidanM SheikhiS TaştanÖ ParodiA LiaoZ Bioactive peptides: An alternative therapeutic approach for cancer management.Front Immunol202415131044310.3389/fimmu.2024.131044338327525
     [Google Scholar]
  8. OrtizE. GurrolaG.B. SchwartzE.F. PossaniL.D. Scorpion venom components as potential candidates for drug development.Toxicon20159312513510.1016/j.toxicon.2014.11.23325432067
     [Google Scholar]
  9. FawzyB.S. NafieM.S. AliI.A.I. El-BazL.M.F. XuX. Abdel-RahmanM.A. Scorpion venom peptide smp24 revealed apoptotic and antiangiogenic activities in solid-ehrlich carcinoma bearing mice.Int. J. Pept. Res. Ther.20232922910.1007/s10989‑023‑10494‑6
     [Google Scholar]
  10. Sarfo-PokuC. EshunO. LeeK.H. Medical application of scorpion venom to breast cancer: A mini-review.Toxicon201612210911210.1016/j.toxicon.2016.09.00527644898
     [Google Scholar]
  11. EjazS. HashmiF.B. MalikW.N. AshrafM. NasimF.H. IqbalM. Applications of venom proteins as potential anticancer agents.Protein Pept. Lett.201825768870110.2174/092986652466618061410210429921199
     [Google Scholar]
  12. MikaelianA.G. TraboulayE. ZhangX.M. YeritsyanE. PedersenP.L. KoY.H. MatalkaK.Z. Pleiotropic anticancer properties of scorpion venom peptides: rhopalurus princeps venom as an anticancer agent.Drug Des. Devel. Ther.20201488189310.2147/DDDT.S23100832161447
     [Google Scholar]
  13. Yglesias-RiveraA. Sánchez-MamposoA.M. Díaz-GarcíaA. Rodríguez-SánchezH. Synergism of the combination of Rhopalurus junceus scorpion venom with conventional cytostatics in the ct26 tumor cell line.Asian J Biomed Pharmaceut Sci20201069110.35841/2249‑622X.69.4552
     [Google Scholar]
  14. HarrisonP.L. Abdel-RahmanM.A. MillerK. StrongP.N. Antimicrobial peptides from scorpion venoms.Toxicon20148811513710.1016/j.toxicon.2014.06.00624951876
     [Google Scholar]
  15. Al-AsmariA.K. IslamM. Al-ZahraniA.M. in vitro analysis of the anticancer properties of scorpion venom in colorectal and breast cancer cell lines.Oncol. Lett.20161121256126210.3892/ol.2015.403626893728
     [Google Scholar]
  16. Bernardes-OliveiraE. FariasK.J.S. GomesD.L. de AraújoJ.M.G. da SilvaW.D. RochaH.A.O. DonadiE.A. Fernandes-PedrosaM.F. CrispimJ.C.O. Tityus serrulatus scorpion venom induces apoptosis in cervical cancer cell lines.Evid. Based Complement. Alternat. Med.201920191513104231341494
     [Google Scholar]
  17. Al-AsmariA. RiyasdeenA. AbbasmanthiriR. ArshaduddinM. Al-HarthiF. Scorpion (Androctonus bicolor) venom exhibits cytotoxicity and induces cell cycle arrest and apoptosis in breast and colorectal cancer cell lines.Indian J. Pharmacol.201648553754310.4103/0253‑7613.19074227721540
     [Google Scholar]
  18. Al-AsmariA.K. RiyasdeenA. IslamM. Scorpion venom causes upregulation of p53 and downregulation of Bcl-xL and BID protein expression by modulating signaling proteins Erk1/2 and STAT3, and DNA damage in breast and colorectal cancer cell lines.Integr. Cancer Ther.201817227128110.1177/153473541770494928438053
     [Google Scholar]
  19. Al-SadoonM.K. Abdel-MaksoudM.A. RabahD.M. BadrG. Induction of apoptosis and growth arrest in human breast carcinoma cells by a snake (Walterinnesia aegyptia) venom combined with silica nanoparticles: Crosstalk between Bcl2 and caspase 3.Cell. Physiol. Biochem.201230365366510.1159/00034144622854437
     [Google Scholar]
  20. El-FikyA. EldousoukyA. ElkhashabD. Effect of the egyptian sahara sand viper venom on human breast cancer: An in vitro study.J. Egypt. Soc. Parasitol.201949358959810.21608/jesp.2019.68062
     [Google Scholar]
  21. BradshawM.J. SaviolaA.J. FeslerE. MackessyS.P. Evaluation of cytotoxic activities of snake venoms toward breast (MCF-7) and skin cancer (A-375) cell lines.Cytotechnology201668468770010.1007/s10616‑014‑9820‑225407733
     [Google Scholar]
  22. OfforB.C. PiaterL.A. Snake venom toxins: Potential anticancer therapeutics.J. Appl. Toxicol.202444566668510.1002/jat.454437697914
     [Google Scholar]
  23. RadyI. SiddiquiI.A. RadyM. MukhtarH. Melittin, a major peptide component of bee venom, and its conjugates in cancer therapy.Cancer Lett.2017402163110.1016/j.canlet.2017.05.01028536009
     [Google Scholar]
  24. YuJ.E. KimY. HongD.E. LeeD.W. ChangJ.Y. YooS.S. KimM.J. SonD.J. YunJ. HanS.B. HongJ.T. Bee venom triggers autophagy-induced apoptosis in human lung cancer cells via the mtor signaling pathway.J. Oncol.2022202211310.1155/2022/891646436590307
     [Google Scholar]
  25. Desales-SalazarE. KhusroA. Cipriano-SalazarM. Barbabosa-PliegoA. Rivas-CaceresR.R. Scorpion venoms and associated toxins as anticancer agents: Update on their application and mechanism of action.J. Appl. Toxicol.202040101310132410.1002/jat.397632249452
     [Google Scholar]
  26. AhmadiS. KnerrJ.M. ArgemiL. BordonK.C.F. PuccaM.B. CerniF.A. ArantesE.C. ÇalışkanF. LaustsenA.H. Scorpion venom: Detriments and benefits.Biomedicines20208511810.3390/biomedicines805011832408604
     [Google Scholar]
  27. LourençoW.R. The evolution and distribution of noxious species of scorpions (Arachnida: Scorpiones).J. Venom. Anim. Toxins Incl. Trop. Dis.2018241110.1186/s40409‑017‑0138‑329308066
     [Google Scholar]
  28. WardM.J. EllsworthS.A. NystromG.S. A global accounting of medically significant scorpions: Epidemiology, major toxins, and comparative resources in harmless counterparts.Toxicon201815113715510.1016/j.toxicon.2018.07.00730009779
     [Google Scholar]
  29. SimoneY. MeijdenA. Armed stem to stinger: A review of the ecological roles of scorpion weapons.J. Venom. Anim. Toxins Incl. Trop. Dis.202127e2021000210.1590/1678‑9199‑jvatitd‑2021‑000234527038
     [Google Scholar]
  30. GoudetC. ChiC.W. TytgatJ. An overview of toxins and genes from the venom of the Asian scorpion Buthus martensi Karsch.Toxicon20024091239125810.1016/S0041‑0101(02)00142‑312220709
     [Google Scholar]
  31. ChenY. XuE. SangM. WangZ. ZhangY. YeJ. ZhouQ. ZhaoC. HuC. LuW. CaoP. Makatoxin-3, a thermostable Nav1.7 agonist from Buthus martensii Karsch (BmK) scorpion elicits non-narcotic analgesia in inflammatory pain models.J. Ethnopharmacol.202228811499810.1016/j.jep.2022.11499835063590
     [Google Scholar]
  32. Monge-FuentesV GomesFMM CamposGAA Neuroactive compounds obtained from arthropod venoms as new therapeutic platforms for the treatment of neurological disorders.J Venom Anim Toxins Incl Trop Dis2015213110.1186/s40409‑015‑0031‑x26257776
     [Google Scholar]
  33. RazaM. ShaheenF. ChoudharyM.I. SombatiS. RafiqA. SuriaA. RahmanA. DeLorenzoR.J. Anticonvulsant activities of ethanolic extract and aqueous fraction isolated from Delphinium denudatum.J. Ethnopharmacol.2001781737810.1016/S0378‑8741(01)00327‑011585691
     [Google Scholar]
  34. VillettiG. BregolaG. BassaniF. BergamaschiM. RondelliI. PietraC. SimonatoM. Preclinical evaluation of CHF3381 as a novel antiepileptic agent.Neuropharmacology200140786687810.1016/S0028‑3908(01)00026‑011378157
     [Google Scholar]
  35. BawaskarH.S. BawaskarP.H. Efficacy and safety of scorpion antivenom plus prazosin compared with prazosin alone for venomous scorpion (Mesobuthus tamulus) sting: Randomised open label clinical trial.BMJ2011342jan05 3c713610.1136/bmj.c713621209062
     [Google Scholar]
  36. Shokry ZagharyM.M. Abd ElKaderM.M. A comparative study of using scorpion antivenom versus scorpion antivenom and prazosin drug for scorpion stings management in Sohag University Hospitals.BMC Pharmacol. Toxicol.20252613110.1186/s40360‑025‑00854‑x39953590
     [Google Scholar]
  37. Cloudsley-ThompsonJ. Scorpions in mythology, folklore, and history.The biology of scorpionsStanford University PressCalifornia1990462485
     [Google Scholar]
  38. LingC. ZhangY. LiJ. ChenW. LingC. Clinical use of toxic proteins and peptides from Tian Hua Fen and scorpion venom.Curr. Protein Pept. Sci.201920328529510.2174/138920371966618062210064129932034
     [Google Scholar]
  39. JiaZ. ZhuX. ZhouY. WuJ. CaoM. HuC. YuL. XuR. ChenZ. Polypeptides from traditional Chinese medicine: Comprehensive review of perspective towards cancer management.Int. J. Biol. Macromol.2024260Pt 112942310.1016/j.ijbiomac.2024.12942338232868
     [Google Scholar]
  40. ShaoJ.H. CuiY. ZhaoM.Y. WuC.F. LiuY.F. ZhangJ.H. Purification, characterization, and bioactivity of a new analgesic-antitumor peptide from Chinese scorpion Buthus martensii Karsch.Peptides201453899610.1016/j.peptides.2013.10.02324269605
     [Google Scholar]
  41. ZhouX.H. YangD. ZhangJ.H. LiuC.M. LeiK.J. Purification and N -terminal partial sequence of anti-epilepsy peptide from venom of the scorpion Buthus martensii Karsch.Biochem. J.1989257250951710.1042/bj25705092930463
     [Google Scholar]
  42. GaoB. XuJ. del Carmen RodriguezM. Lanz-MendozaH. Hernández-RivasR. DuW. ZhuS. Characterization of two linear cationic antimalarial peptides in the scorpion Mesobuthus eupeus.Biochimie201092435035910.1016/j.biochi.2010.01.01120097251
     [Google Scholar]
  43. HeinenT.E. Gorini da VeigaA.B. Arthropod venoms and cancer.Toxicon201157449751110.1016/j.toxicon.2011.01.00221236287
     [Google Scholar]
  44. SuhasR. Structure, function and mechanistic aspects of scorpion venom peptides - A boon for the development of novel therapeutics.Eur. J. Med. Chem. Rep.2022610006810.1016/j.ejmcr.2022.100068
     [Google Scholar]
  45. CaoZ. DiZ. WuY. LiW. Overview of scorpion species from China and their toxins.Toxins20146379681510.3390/toxins603079624577583
     [Google Scholar]
  46. ZhengFan Ctriporin, a new anti-methicillin-resistant Staphylococcus aureus peptide from the venom of the scorpion Chaerilus tricostatus.Antimicrob Agents Chemother201155115220522910.1128/AAC.00369‑1121876042
     [Google Scholar]
  47. ChenR. ChungS.H. Engineering a potent and specific blocker of voltage-gated potassium channel Kv1.3, a target for autoimmune diseases.Biochemistry20125191976198210.1021/bi201811j22352687
     [Google Scholar]
  48. RajputS.S. MohanH. JadhavE. SononeS.S. NagarV. SinghA. ChopadeR.L. AwasthiK.K. SankhlaM.S. Therapeutic potential of scorpion venom in cancer treatment as anticancer agent: A review.Journal of Forensic Medicine and Toxicology202138210511710.5958/0974‑4568.2021.00044.2
     [Google Scholar]
  49. Al-AsmariA.K. KunnathodiF. Al SaadonK. IdrisM.M. nlmal analysis of scorpion venoms.J. Venom Res.20167162027826410
     [Google Scholar]
  50. GopalakrishnakoneP. CheahJ. GweeM.C.E. Black scorpion (Heterometrus longimanus) as a laboratory animal: Maintenance of a colony of scorpion for milking of venom for research, using a restraining device.Lab. Anim.199529445645810.1258/0023677957807400508558832
     [Google Scholar]
  51. ChiarielloTM Captive maintenance and venom extraction of Tityus serrulatus (Brazilian yellow scorpion) for antivenom production.J Vis Exp2023202320010.3791/6573737870320
     [Google Scholar]
  52. GomesA BhattacharjeeP MishraR BiswasAK DasguptaSC GiriB Anticancer potential of animal venoms and toxins.Indian J Exp Biol20104829310320455317
     [Google Scholar]
  53. Al-AsmariA.K. RiyasdeenA. IslamM. Scorpion venom causes apoptosis by increasing reactive oxygen species and cell cycle arrest in MDA-MB-231 and HCT-8 cancer cell lines.J. Evid. Based Integr. Med.201823215658721775179610.1177/215658721775179629405760
     [Google Scholar]
  54. CapatinaA.L. LagosD. BrackenburyW.J. Targeting Ion channels for cancer treatment: Current progress and future challenges.Rev. Physiol. Biochem. Pharmacol.202218314332865696
     [Google Scholar]
  55. SontheimerH. An unexpected role for ion channels in brain tumor metastasis.Exp. Biol. Med.2008233777979110.3181/0711‑MR‑30818445774
     [Google Scholar]
  56. GriffinM. KhanR. BasuS. SmithS. Ion channels as therapeutic targets in high grade gliomas.Cancers20201210306810.3390/cancers1210306833096667
     [Google Scholar]
  57. NorthcottP.A. DubucA.M. PfisterS. TaylorM.D. Molecular subgroups of medulloblastoma.Expert Rev. Neurother.201212787188410.1586/ern.12.6622853794
     [Google Scholar]
  58. ComesN. BielanskaJ. Vallejo-GraciaA. Serrano-AlbarrásA. MarruecosL. GómezD. SolerC. CondomE. Ramón y CajalS. Hernández-LosaJ. FerreresJ.C. FelipeA. The voltage-dependent K+ channels Kv1.3 and Kv1.5 in human cancer.Front. Physiol.2013428310.3389/fphys.2013.0028324133455
     [Google Scholar]
  59. ComesN. Serrano-AlbarrásA. CaperaJ. Serrano-NovilloC. CondomE. Ramón y CajalS. FerreresJ.C. FelipeA. Involvement of potassium channels in the progression of cancer to a more malignant phenotype.Biochim. Biophys. Acta Biomembr.20151848102477249210.1016/j.bbamem.2014.12.00825517985
     [Google Scholar]
  60. BustinS.A. LiS.R. DorudiS. Expression of the Ca2+-activated chloride channel genes CLCA1 and CLCA2 is downregulated in human colorectal cancer.DNA Cell Biol.200120633133810.1089/1044549015212244211445004
     [Google Scholar]
  61. UllrichN. SontheimerH. Biophysical and pharmacological characterization of chloride currents in human astrocytoma cells.Am. J. Physiol. Cell Physiol.19962705C1511C152110.1152/ajpcell.1996.270.5.C15118967454
     [Google Scholar]
  62. DeshaneJ. GarnerC.C. SontheimerH. Chlorotoxin inhibits glioma cell invasion via matrix metalloproteinase-2.J. Biol. Chem.200327864135414410.1074/jbc.M20566220012454020
     [Google Scholar]
  63. McFerrinM.B. SontheimerH. A role for ion channels in glioma cell invasion.Neuron Glia Biol.200621394910.1017/S1740925X0600004416520829
     [Google Scholar]
  64. SaraswatI. GoelA. Cervical cancer therapeutics: An in-depth significance of herbal and chemical approaches of nanoparticles.Anticancer. Agents Med. Chem.202424862763610.2174/011871520628946824013005110238299417
     [Google Scholar]
  65. DeBinJ.A. MaggioJ.E. StrichartzG.R. Purification and characterization of chlorotoxin, a chloride channel ligand from the venom of the scorpion.Am. J. Physiol. Cell Physiol.19932642C361C36910.1152/ajpcell.1993.264.2.C3618383429
     [Google Scholar]
  66. VeisehM. GabikianP. BahramiS.B. VeisehO. ZhangM. HackmanR.C. RavanpayA.C. StroudM.R. KusumaY. HansenS.J. KwokD. MunozN.M. SzeR.W. GradyW.M. GreenbergN.M. EllenbogenR.G. OlsonJ.M. Tumor paint: A chlorotoxin:Cy5.5 bioconjugate for intraoperative visualization of cancer foci.Cancer Res.200767146882688810.1158/0008‑5472.CAN‑06‑394817638899
     [Google Scholar]
  67. BoltmanT. MeyerM. EkpoO. Diagnostic and therapeutic approaches for glioblastoma and neuroblastoma cancers using chlorotoxin nanoparticles.Cancers20231513338810.3390/cancers1513338837444498
     [Google Scholar]
  68. FuY. AnN. LiK. ZhengY. LiangA. Chlorotoxin-conjugated nanoparticles as potential glioma-targeted drugs.J. Neurooncol.2012107345746210.1007/s11060‑011‑0763‑622108716
     [Google Scholar]
  69. WangY. LiK. HanS. TianY. HuP. XuX. HeY. PanW. GaoY. ZhangZ. ZhangJ. WeiL. Chlorotoxin targets ERα/VASP signaling pathway to combat breast cancer.Cancer Med.2019841679169310.1002/cam4.201930806044
     [Google Scholar]
  70. ChungS. SugimotoY. HuangJ. ZhangM. Iron oxide nanoparticles decorated with functional peptides for a targeted siRNA delivery to glioma cells.ACS Appl. Mater. Interfaces202315110611910.1021/acsami.2c1780236442077
     [Google Scholar]
  71. LiJ. ZengH. YouY. WangR. TanT. WangW. YinL. ZengZ. ZengY. XieT. Active targeting of orthotopic glioma using biomimetic liposomes co-loaded elemene and cabazitaxel modified by transferritin.J. Nanobiotechnology202119128910.1186/s12951‑021‑01048‑334565383
     [Google Scholar]
  72. ChenY. DengY. ZhuC. XiangC. Anti prostate cancer therapy: Aptamer-functionalized, curcumin and cabazitaxel co-delivered, tumor targeted lipid-polymer hybrid nanoparticles.Biomed. Pharmacother.202012711018110.1016/j.biopha.2020.11018132416561
     [Google Scholar]
  73. AydarE. YeoS. DjamgozM. PalmerC. Abnormal expression, localization and interaction of canonical transient receptor potential ion channels in human breast cancer cell lines and tissues: A potential target for breast cancer diagnosis and therapy.Cancer Cell Int.2009912310.1186/1475‑2867‑9‑2319689790
     [Google Scholar]
  74. BrayF. LaversanneM. SungH. FerlayJ. SiegelR.L. SoerjomataramI. JemalA. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J. Clin.202474322926310.3322/caac.2183438572751
     [Google Scholar]
  75. LiuB. ZhouH. TanL. SiuK.T.H. GuanX.Y. Exploring treatment options in cancer: Tumor treatment strategies.Signal Transduct. Target. Ther.20249117510.1038/s41392‑024‑01856‑739013849
     [Google Scholar]
  76. MendesL.C. VianaG.M.M. NencioniA.L.A. PimentaD.C. Beraldo-NetoE. Scorpion peptides and ion channels: An insightful review of mechanisms and drug development.Toxins202315423810.3390/toxins1504023837104176
     [Google Scholar]
  77. PeruzzoR. BiasuttoL. SzabòI. LeanzaL. Impact of intracellular ion channels on cancer development and progression.Eur. Biophys. J.201645768570710.1007/s00249‑016‑1143‑027289382
     [Google Scholar]
  78. DingJ. ChuaP.J. BayB.H. GopalakrishnakoneP. Scorpion venoms as a potential source of novel cancer therapeutic compounds.Exp. Biol. Med.2014239438739310.1177/153537021351399124599885
     [Google Scholar]
  79. SmallwoodT.B. ClarkR.J. Advances in venom peptide drug discovery: Where are we at and where are we heading?Expert Opin. Drug Discov.202116101163117310.1080/17460441.2021.192238633914674
     [Google Scholar]
  80. JangS.H. ChoiS.Y. RyuP.D. LeeS.Y. Anti-proliferative effect of Kv1.3 blockers in A549 human lung adenocarcinoma in vitro and in vivo .Eur. J. Pharmacol.20116511-3263210.1016/j.ejphar.2010.10.06621087602
     [Google Scholar]
  81. AissaouiD. Mlayah-BellalounaS. JebaliJ. Abdelkafi-KoubaaZ. SouidS. MoslahW. OthmanH. LuisJ. ElAyebM. MarrakchiN. Essafi-BenkhadirK. Srairi-AbidN. Functional role of Kv1.1 and Kv1.3 channels in the neoplastic progression steps of three cancer cell lines, elucidated by scorpion peptides.Int. J. Biol. Macromol.20181111146115510.1016/j.ijbiomac.2018.01.14429415410
     [Google Scholar]
  82. CandiaS. GarciaM.L. LatorreR. Mode of action of iberiotoxin, a potent blocker of the large conductance Ca(2+)-activated K+ channel.Biophys. J.199263258359010.1016/S0006‑3495(92)81630‑21384740
     [Google Scholar]
  83. WeaverA.K. LiuX. SontheimerH. Role for calcium-activated potassium channels (BK) in growth control of human malignant glioma cells.J. Neurosci. Res.200478222423410.1002/jnr.2024015378515
     [Google Scholar]
  84. TorresA.M. BansalP. AlewoodP.F. BursillJ.A. KuchelP.W. VandenbergJ.I. Solution structure of CnErg1 (Ergtoxin), a HERG specific scorpion toxin.FEBS Lett.20035391-313814210.1016/S0014‑5793(03)00216‑312650941
     [Google Scholar]
  85. AsherV. WarrenA. ShawR. SowterH. BaliA. KhanR. The role of Eag and HERG channels in cell proliferation and apoptotic cell death in SK-OV-3 ovarian cancer cell line.Cancer Cell Int.2011111610.1186/1475‑2867‑11‑621392380
     [Google Scholar]
  86. SchwabA. ReinhardtJ. SchneiderS.W. GassnerB. SchurichtB. K(+) channel-dependent migration of fibroblasts and human melanoma cells.Cell. Physiol. Biochem.19999312613210.1159/00001630910494026
     [Google Scholar]
  87. MamelakA.N. RosenfeldS. BucholzR. RaubitschekA. NaborsL.B. FiveashJ.B. ShenS. KhazaeliM.B. ColcherD. LiuA. OsmanM. GuthrieB. Schade-BijurS. HablitzD.M. AlvarezV.L. GondaM.A. Phase I single-dose study of intracavitary-administered iodine-131-TM-601 in adults with recurrent high-grade glioma.J. Clin. Oncol.200624223644365010.1200/JCO.2005.05.456916877732
     [Google Scholar]
  88. OjedaP.G. WangC.K. CraikD.J. Chlorotoxin: Structure, activity, and potential uses in cancer therapy.Biopolymers20161061253610.1002/bip.2274826418522
     [Google Scholar]
  89. SunN. ZhaoL. QiaoW. XingY. ZhaoJ. BmK CT and 125I-BmK CT suppress the invasion of glioma cells in vitro via matrix metalloproteinase-2.Mol. Med. Rep.20171552703270810.3892/mmr.2017.628428260030
     [Google Scholar]
  90. RjeibiI. MabroukK. MosratiH. BerenguerC. MejdoubH. VillardC. LaffitteD. BertinD. OuafikL.H. LuisJ. ElAyebM. Srairi-AbidN. Purification, synthesis and characterization of AaCtx, the first chlorotoxin-like peptide from Androctonus australis scorpion venom.Peptides201132465666310.1016/j.peptides.2011.01.01521262299
     [Google Scholar]
  91. KirschG.E. SkattebølA. PossaniL.D. BrownA.M. Modification of Na channel gating by an alpha scorpion toxin from Tityus serrulatus.J. Gen. Physiol.1989931678310.1085/jgp.93.1.672536799
     [Google Scholar]
  92. GuoX. MaC. DuQ. WeiR. WangL. ZhouM. ChenT. ShawC. Two peptides, TsAP-1 and TsAP-2, from the venom of the Brazilian yellow scorpion, Tityus serrulatus: Evaluation of their antimicrobial and anticancer activities.Biochimie20139591784179410.1016/j.biochi.2013.06.00323770440
     [Google Scholar]
  93. EscalonaM.P. BatistaC.V.F. CassuliniR.R. RiosM.S. CoronasF.I. PossaniL.D. A proteomic analysis of the early secondary molecular effects caused by Cn2 scorpion toxin on neuroblastoma cells.J. Proteomics201411121222310.1016/j.jprot.2014.04.03524792703
     [Google Scholar]
  94. KampoS. AhmmedB. ZhouT. OwusuL. AnabahT.W. DoudouN.R. KuugbeeE.D. CuiY. LuZ. YanQ. WenQ.P. Scorpion venom analgesic peptide, BmK AGAP inhibits stemness, and epithelial-mesenchymal transition by down-regulating PTX3 in breast cancer.Front. Oncol.201992110.3389/fonc.2019.0002130740360
     [Google Scholar]
  95. GuY. LiuS.L. JuW.Z. LiC.Y. CaoP. Analgesic-antitumor peptide induces apoptosis and inhibits the proliferation of SW480 human colon cancer cells.Oncol. Lett.20135248348810.3892/ol.2012.104923420047
     [Google Scholar]
  96. ZhaoY. CaiX. YeT. HuoJ. LiuC. ZhangS. CaoP. Analgesic-antitumor peptide inhibits proliferation and migration of SHG-44 human malignant glioma cells.J. Cell. Biochem.201111292424243410.1002/jcb.2316621538480
     [Google Scholar]
  97. GuoG. CuiY. ChenH. ZhangL. ZhaoM. ChenB. ZhangJ. LiuY. Analgesic-antitumor peptide inhibits the migration and invasion of HepG2 cells by an upregulated VGSC β1 subunit.Tumour Biol.20163733033304110.1007/s13277‑015‑4067‑x26419595
     [Google Scholar]
  98. KaurG. RoyB. Decoding tumor angiogenesis for therapeutic advancements: Mechanistic insights.Biomedicines202412482710.3390/biomedicines1204082738672182
     [Google Scholar]
  99. LiuZ.L. ChenH.H. ZhengL.L. SunL.P. ShiL. Angiogenic signaling pathways and anti-angiogenic therapy for cancer.Signal Transduct. Target. Ther.20238119810.1038/s41392‑023‑01460‑137169756
     [Google Scholar]
  100. PragerG.W. PoettlerM. UnseldM. ZielinskiC.C. Angiogenesis in cancer: Anti-VEGF escape mechanisms.Transl. Lung Cancer Res.201211142525806151
     [Google Scholar]
  101. SalemM.L. ShoukryN.M. TelebW.K. Abdel-DaimM.M. Abdel-RahmanM.A. in vitro and in vivo antitumor effects of the Egyptian scorpion Androctonus amoreuxi venom in an Ehrlich ascites tumor model.Springerplus20165157010.1186/s40064‑016‑2269‑327247867
     [Google Scholar]
  102. WangX. WangZ. ZhangY. JiaQ. WangZ. ZhangJ. ZhangW. Mechanisms for inhibition effects of polypeptide extract from scorpion venom (PESV) on proliferation of A549 cell lines in vitro.Zhongguo Zhongyao Zazhi201237111620162322993994
     [Google Scholar]
  103. SuiW.W. ZhangW.D. WuL.C. ZhangY.Y. WangZ.P. WangZ.X. JiaQ. Study on the mechanism of polypeptide extract from scorpion venom on inhibition of angiogenesis of H 22 hepatoma.Chung Kuo Chung Hsi I Chieh Ho Tsa Chih201434558158624941848
     [Google Scholar]
  104. Al-AsmariA. KhanA. Investigation of in vivo potential of scorpion venom against skin tumorigenesis in mice via targeting markers associated with cancer development.Drug Des. Devel. Ther.2016103387339710.2147/DDDT.S11317127799739
     [Google Scholar]
  105. XuT. FanZ. LiW. DietelB. WuY. BeckmannM.W. WroschJ.K. BuchfelderM. EyupogluI.Y. CaoZ. SavaskanN.E. Identification of two novel Chlorotoxin derivatives CA4 and CTX-23 with chemotherapeutic and anti-angiogenic potential.Sci. Rep.2016611979910.1038/srep1979926831010
     [Google Scholar]
  106. SongZ. WangJ. SuQ. LuanM. ChenX. XuX. The role of MMP-2 and MMP-9 in the metastasis and development of hypopharyngeal carcinoma.Rev. Bras. Otorrinolaringol. (Engl. Ed.)202187552152831882379
     [Google Scholar]
  107. ChaudharyA.K. SinghM. BhartiA.C. AsotraK. SundaramS. MehrotraR. Genetic polymorphisms of matrix metalloproteinases and their inhibitors in potentially malignant and malignant lesions of the head and neck.J. Biomed. Sci.20101711010.1186/1423‑0127‑17‑1020152059
     [Google Scholar]
  108. SakK. The low expression of matrix metalloproteinases: A key to longevity?Explor. Med.20245215816610.37349/emed.2024.00213
     [Google Scholar]
  109. SincevičiūtėR. VaitkienėP. UrbanavičiūtėR. SteponaitisG. TamašauskasA. SkiriutėD. MMP2 is associated with glioma malignancy and patient outcome.Int. J. Clin. Exp. Pathol.20181163010301831938426
     [Google Scholar]
  110. El-GhlbanS. KasaiT. ShigehiroT. YinH.X. SekharS. IdaM. SanchezA. MizutaniA. KudohT. MurakamiH. SenoM. Chlorotoxin-Fc fusion inhibits release of MMP-2 from pancreatic cancer cells.BioMed Res. Int.2014201411010.1155/2014/15265924511528
     [Google Scholar]
  111. FuY.J. YinL.T. LiangA.H. ZhangC.F. WangW. ChaiB.F. YangJ.Y. FanX.J. Therapeutic potential of chlorotoxin-like neurotoxin from the Chinese scorpion for human gliomas.Neurosci. Lett.20074121626710.1016/j.neulet.2006.10.05617166663
     [Google Scholar]
  112. FuY.J. AnN. ChanK.G. WuY.B. ZhengS.H. LiangA.H. A model of BmK CT in inhibiting glioma cell migration via matrix metalloproteinase-2 from experimental and molecular dynamics simulation study.Biotechnol. Lett.20113371309131710.1007/s10529‑011‑0587‑721424168
     [Google Scholar]
  113. RameshP. MedemaJ.P. BCL-2 family deregulation in colorectal cancer: Potential for BH3 mimetics in therapy.Apoptosis2020255-630532010.1007/s10495‑020‑01601‑932335811
     [Google Scholar]
  114. MohammadR.M. MuqbilI. LoweL. YedjouC. HsuH.-Y. LinL.-T. SiegelinM.D. FimognariC. KumarN.B. DouQ.P. YangH. SamadiA.K. RussoG.L. SpagnuoloC. RayS.K. ChakrabartiM. MorreJ.D. ColeyH.M. HonokiK. FujiiH. GeorgakilasA.G. AmedeiA. NiccolaiE. AminA. AshrafS.S. HelferichW.G. YangX. BoosaniC.S. GuhaG. BhaktaD. CirioloM.R. AquilanoK. ChenS. MohammedS.I. KeithW.N. BilslandA. HalickaD. NowsheenS. AzmiA.S. Broad targeting of resistance to apoptosis in cancer.Seminars in cancer biology.Elsevier201510.1016/j.semcancer.2015.03.001
     [Google Scholar]
  115. D’SuzeG. RosalesA. SalazarV. SevcikC. Apoptogenic peptides from Tityus discrepans scorpion venom acting against the SKBR3 breast cancer cell line.Toxicon20105681497150510.1016/j.toxicon.2010.09.00820888852
     [Google Scholar]
  116. Tong-ngamP. RoytrakulS. SritanaudomchaiH. BmKn-2 scorpion venom peptide for killing oral cancer cells by apoptosis.Asian Pac. J. Cancer Prev.20151672807281110.7314/APJCP.2015.16.7.280725854366
     [Google Scholar]
  117. ZarganJ. SajadM. UmarS. NaimeM. AliS. KhanH.A. Scorpion (Odontobuthus doriae) venom induces apoptosis and inhibits DNA synthesis in human neuroblastoma cells.Mol. Cell. Biochem.20113481-217318110.1007/s11010‑010‑0652‑x21061047
     [Google Scholar]
  118. ZarganJ. UmarS. SajadM. NaimeM. AliS. KhanH.A. Scorpion venom (Odontobuthus doriae) induces apoptosis by depolarization of mitochondria and reduces S-phase population in human breast cancer cells (MCF-7). Toxicol. In vitro 20112581748175610.1016/j.tiv.2011.09.00221945044
     [Google Scholar]
  119. LiB. LyuP. XiX. GeL. MahadevappaR. ShawC. KwokH.F. Triggering of cancer cell cycle arrest by a novel scorpion venom-derived peptide—Gonearrestide.J. Cell. Mol. Med.20182294460447310.1111/jcmm.1374529993185
     [Google Scholar]
  120. ZarganJ. SajadM. UmarS. NaimeM. AliS. KhanH.A. Scorpion (Androctonus crassicauda) venom limits growth of transformed cells (SH-SY5Y and MCF-7) by cytotoxicity and cell cycle arrest.Exp. Mol. Pathol.201191144745410.1016/j.yexmp.2011.04.00821536027
     [Google Scholar]
  121. RapôsoC. Scorpion and spider venoms in cancer treatment: State of the art, challenges, and perspectives.J. Clin. Transl. Res.20173223324910.18053/jctres.03.201702.00230873475
     [Google Scholar]
  122. ZhangY.Y. WuL.C. WangZ.P. WangZ.X. JiaQ. JiangG.S. ZhangW.D. Anti-proliferation effect of polypeptide extracted from scorpion venom on human prostate cancer cells in vitro .J. Clin. Med. Res.200911243110.4021/jocmr2009.01.122022505961
     [Google Scholar]
  123. Coulter-ParkhillA. McCleanS. GaultV.A. IrwinN. Therapeutic potential of peptides derived from animal venoms: Current views and emerging drugs for diabetes.Clin. Med. Insights Endocrinol. Diabetes20211410.1177/1179551421100607134621137
     [Google Scholar]
  124. DastpeymanM. GiacominP. WilsonD. NolanM.J. BansalP.S. DalyN.L. A C-terminal fragment of chlorotoxin retains bioactivity and inhibits cell migration.Front. Pharmacol.20191025010.3389/fphar.2019.0025030949052
     [Google Scholar]
  125. DardevetL. RaniD. AzizT. BazinI. SabatierJ.M. FadlM. BrambillaE. De WaardM. Chlorotoxin: A helpful natural scorpion peptide to diagnose glioma and fight tumor invasion.Toxins2015741079110110.3390/toxins704107925826056
     [Google Scholar]
  126. WuX.S. JianX.C. YinB. HeZ.J. Development of the research on the application of chlorotoxin in imaging diagnostics and targeted therapies for tumors.Chin. J. Cancer201029662663010.5732/cjc.009.1035920507737
     [Google Scholar]
  127. ZhaoL. ZhuJ. ChengY. XiongZ. TangY. GuoL. ShiX. ZhaoJ. Chlorotoxin-conjugated multifunctional dendrimers labeled with radionuclide 131 i for single photon emission computed tomography imaging and radiotherapy of gliomas.ACS Appl. Mater. Interfaces2015735197981980810.1021/acsami.5b0583626291070
     [Google Scholar]
  128. YamadaM. MillerD.M. LoweM. RoweC. WoodD. SoyerH.P. Byrnes-BlakeK. Parrish-NovakJ. IshakL. OlsonJ.M. BrandtG. GriffinP. SpelmanL. ProwT.W. A first-in-human study of BLZ-100 (tozuleristide) demonstrates tolerability and safety in skin cancer patients.Contemp. Clin. Trials Commun.20212310083010.1016/j.conctc.2021.10083034401600
     [Google Scholar]
  129. LafnouneA. LeeS.Y. HeoJ.Y. DaoudiK. DarkaouiB. ChakirS. CadiR. MounajiK. ShumD. SeoH.R. OukkacheN. Anti-cancer activity of buthus occitanus venom on hepatocellular carcinoma in 3D cell culture.Molecules2022277221910.3390/molecules2707221935408621
     [Google Scholar]
  130. KeshavarzH. ZarganJ. BidmeshkipourA. NaghnehE. HajinourmohammadiA. ZamaniE. Low molecular weight peptides derived from Iranian Scorpion (Odontobuthus bidentatus) Venom Induces Apoptosis in the Hepatocellular Carcinoma Cell Line (HepG2) in 3D Cell Culture.Res. Sq.202310.21203/rs.3.rs‑3161544/v1
     [Google Scholar]
  131. LiW. XinY. ChenY. LiX. ZhangC. BaiJ. YuanJ. The anti-proliferative effects and mechanisms of low molecular weight scorpion BmK venom peptides on human hepatoma and cervical carcinoma cells in vitro .Oncol. Lett.2014841581158410.3892/ol.2014.233625202371
     [Google Scholar]
  132. ChaiJ. YangW. GaoY. GuoR. PengQ. Abdel-RahmanM.A. XuX. Antitumor effects of scorpion peptide smp43 through mitochondrial dysfunction and membrane disruption on hepatocellular carcinoma.J. Nat. Prod.202184123147316010.1021/acs.jnatprod.1c0096334866381
     [Google Scholar]
  133. ZhengT. ZhangZ. YuZ. WangH. LyuX. HanC. Investigation on the mechanisms of scorpion venom in hepatocellular carcinoma model mice via untargeted metabolomics profiling.Int. Immunopharmacol.202413811257810.1016/j.intimp.2024.11257838959539
     [Google Scholar]
  134. GhoshA. RoyR. NandiM. MukhopadhyayA. Scorpion venom–toxins that aid in drug development: A review.Int. J. Pept. Res. Ther.2019251273710.1007/s10989‑018‑9721‑x32214927
     [Google Scholar]
  135. NafieM.S. Abdel DaimM.M. AliI.A.I. NabilZ.I. TantawyM.A. Abdel-RahmanM.A. Antitumor efficacy of the Egyptian Scorpion Venom Androctonus Australis: in vitro and in vivo study.J. Basic Appl. Zool.20208111010.1186/s41936‑020‑00147‑1
     [Google Scholar]
  136. TelebW.K. TantawyM.A. XuX. HusseinA.A. Abdel-RahmanM.A. Cytotoxicity and molecular alterations induced by scorpion venom antimicrobial peptide Smp43 in breast cancer cell lines MDA-MB-231 and MCF-7.Int. J. Pept. Res. Ther.2022291810.1007/s10989‑022‑10474‑2
     [Google Scholar]
  137. Setayesh-MehrZ. AsoodehA. GhasemiL.V. The anti-cancer effect of two extract fractions from the hemiscorpius lepturus scorpion venom.Appl. Biochem. Microbiol.202359685085710.1134/S0003683823060145
     [Google Scholar]
  138. QinC. HeB. DaiW. ZhangH. WangX. WangJ. ZhangX. WangG. YinL. ZhangQ. Inhibition of metastatic tumor growth and metastasis via targeting metastatic breast cancer by chlorotoxin-modified liposomes.Mol. Pharm.201411103233324110.1021/mp400691z24559485
     [Google Scholar]
  139. Keshavarz AlikhaniH. ZarganJ. BidmeshkipourA. ZamaniE. MosaviM. HeidariA. HajinoormohammadiA. Iranian scorpion (Odontobuthus bidentatus) crude venom change the redox potential of MCF-7 breast cancer cell line and induce apoptosis.Mod Med Lab J202142283510.30699/mmlj17.4.2.28
     [Google Scholar]
  140. AlhakamyN.A. FahmyU.A. Badr EldinS.M. AhmedO.A.A. AldawsariH.M. OkbazghiS.Z. AlfalehM.A. AbdulaalW.H. AlamoudiA.J. MadyF.M. Scorpion venom-functionalized quercetin phytosomes for breast cancer management: in vitro response surface optimization and anticancer activity against MCF-7 cells.Polymers20211419310.3390/polym1401009335012116
     [Google Scholar]
  141. SaidY.M. El-GamelN.E.A. AliS.A. MohamedA.F. Evaluation of Human Wharton’s Jelly-Derived Mesenchymal Stem Cells Conditioning Medium (hWJ-MSCs-CM) or Scorpion Venom Breast Cancer Cell Line in vitro .J. Gastrointest. Cancer202253488890110.1007/s12029‑021‑00762‑334988906
     [Google Scholar]
  142. KhademiZ AyatH ElahianF AhadiAM IOD-NaTx, a scorpion Nav channel toxin induces apoptosis and inhibits growth of highly aggressive breast cancer cells.Res. Sq.202310.21203/rs.3.rs‑2515292/v1
     [Google Scholar]
  143. Díaz-GarcíaA. Ruiz-FuentesJ.L. Frión-HerreraY. Yglesias-RiveraA. GarloboY.R. SánchezH.R. AurrecocheaJ.C.R. López FuentesL.X. Rhopalurus junceus scorpion venom induces antitumor effect in vitro and in vivo against a murine mammary adenocarcinoma model.Iran. J. Basic Med. Sci.201922775976532373297
     [Google Scholar]
  144. Yglesias-RiveraA. Sánchez-RodríguezH. Soto-FeblesC. MonzoteL. Heteroctenus junceus Scorpion Venom Modulates the Concentration of Pro-Inflammatory Cytokines in F3II Tumor Cells.Life20231312228710.3390/life1312228738137888
     [Google Scholar]
  145. JacobsB.A. ChettyA. HorsnellW.G.C. SchäferG. PrinceS. SmithK.A. Hookworm exposure decreases human papillomavirus uptake and cervical cancer cell migration through systemic regulation of epithelial-mesenchymal transition marker expression.Sci. Rep.2018811154710.1038/s41598‑018‑30058‑930069018
     [Google Scholar]
  146. MachadoR.J.A. EstrelaA.B. NascimentoA.K.L. MeloM.M.A. Torres-RêgoM. LimaE.O. RochaH.A.O. CarvalhoE. Silva-JuniorA.A. Fernandes-PedrosaM.F. Characterization of TistH, a multifunctional peptide from the scorpion Tityus stigmurus: Structure, cytotoxicity and antimicrobial activity.Toxicon201611936237010.1016/j.toxicon.2016.06.00227267248
     [Google Scholar]
  147. ZahraS.M. MaryamR. AsgharP. The Role of the HL-10 peptide in regulating the expression of apoptosis-related genes in the hela cancer cell line.Pharm. Chem. J.202457121929193310.1007/s11094‑024‑03098‑x
     [Google Scholar]
  148. AlmaaytahA. TaraziS. MhaidatN. Al-BalasQ. MukattashT.L. Mauriporin, a novel cationic α-helical peptide with selective cytotoxic activity against prostate cancer cell lines from the venom of the scorpion Androctonus mauritanicus.Int. J. Pept. Res. Ther.201319428129310.1007/s10989‑013‑9350‑3
     [Google Scholar]
  149. Al-RabiaM.W. AlhakamyN.A. RizgW.Y. AlghaithA.F. AhmedO.A.A. FahmyU.A. Boosting curcumin activity against human prostatic cancer PC3 cells by utilizing scorpion venom conjugated phytosomes as promising functionalized nanovesicles.Drug Deliv.202229180782010.1080/10717544.2022.204813335266425
     [Google Scholar]
  150. HabibT. HassanH. AliF. MahrousN. Evaluation of Leiurus quinquestriatus scorpion venom anticancer potential against Prostate Cancer Cell Lines (PC3).J. Environ. Stud.201919171310.21608/jesj.2019.204212
     [Google Scholar]
  151. YouX. QiuJ. LiQ. ZhangQ. ShengW. CaoY. FuW. Astragaloside IV-PESV inhibits prostate cancer tumor growth by restoring gut microbiota and microbial metabolic homeostasis via the AGE-RAGE pathway.BMC Cancer202424147210.1186/s12885‑024‑12167‑z38622523
     [Google Scholar]
  152. CommitteeK.C. Bluegrass Coalition for Colorectal Screening KMA Cancer Committee Colorectal cancer facts.J. Ky. Med. Assoc.2005103311815816658
     [Google Scholar]
  153. AitkenJ.B. NaumovskiN. CurryB. GrupenC.G. GibbZ. AitkenR.J. Characterization of an L-amino acid oxidase in equine spermatozoa.Biol Reprod201592512510.1095/biolreprod.114.12605225740544
     [Google Scholar]
  154. Al-AsmariA. UllahZ. Al BalowiA. IslamM. in vitro determination of the efficacy of scorpion venoms as anti-cancer agents against colorectal cancer cells: A nano-liposomal delivery approach.Int. J. Nanomedicine20171255957410.2147/IJN.S12351428144138
     [Google Scholar]
  155. GergesM.M. Abdel-RahmanM.A. RahmyT.R. SharmaP.P. MehanaA.E. Cytotoxic activity and mechanism of action of Smp43 scorpion peptide against colorectal cancer cell line HCT-116.Toxin Rev.202443337038310.1080/15569543.2024.2344471
     [Google Scholar]
  156. MoradiM. NajafiR. AminiR. SolgiR. TanzadehpanahH. EsfahaniA.M. SaidijamM. Remarkable apoptotic pathway of Hemiscorpius lepturus scorpion venom on CT26 cell line.Cell Biol. Toxicol.201935437338510.1007/s10565‑018‑09455‑330617443
     [Google Scholar]
  157. SaginalaK. BarsoukA. AluruJ.S. RawlaP. BarsoukA. Epidemiology of Melanoma.Med. Sci.2021946310.3390/medsci904006334698235
     [Google Scholar]
  158. NorbergE. OrreniusS. ZhivotovskyB. Mitochondrial regulation of cell death: Processing of apoptosis-inducing factor (AIF).Biochem. Biophys. Res. Commun.201039619510010.1016/j.bbrc.2010.02.16320494118
     [Google Scholar]
  159. NabiG. AhmadN. UllahS. DrG. KhanS. Therapeutic applications of scorpion venom in cancer: Mini review.J. Biol. Life Sci.2014615710.5296/jbls.v6i1.6418
     [Google Scholar]
  160. QuastS.A. BergerA. ButtstädtN. FriebelK. SchönherrR. EberleJ. General Sensitization of melanoma cells for TRAIL-induced apoptosis by the potassium channel inhibitor TRAM-34 depends on release of SMAC.PLoS One201276e3929010.1371/journal.pone.003929022723988
     [Google Scholar]
  161. WangW.X. JiY.H. Scorpion venom induces glioma cell apoptosis in vivo and inhibits glioma tumor growth in vitro .J. Neurooncol.20057311710.1007/s11060‑004‑4205‑615933810
     [Google Scholar]
  162. Gómez RaveL.J. Muñoz BravoA.X. Sierra CastrilloJ. Román MarínL.M. Corredor PereiraC. Scorpion venom: New promise in the treatment of cancer.Acta Biol Colomb201924221322310.15446/abc.v24n2.71512
     [Google Scholar]
  163. KesavanK. RatliffJ. JohnsonE.W. DahlbergW. AsaraJ.M. MisraP. FrangioniJ.V. JacobyD.B. Annexin A2 is a molecular target for TM601, a peptide with tumor-targeting and anti-angiogenic effects.J. Biol. Chem.201028574366437410.1074/jbc.M109.06609220018898
     [Google Scholar]
  164. GuptaS.D. GomesA. DebnathA. SahaA. GomesA. Apoptosis induction in human leukemic cells by a novel protein Bengalin, isolated from Indian black scorpion venom: Through mitochondrial pathway and inhibition of heat shock proteins.Chem. Biol. Interact.2010183229330310.1016/j.cbi.2009.11.00619913524
     [Google Scholar]
  165. Das GuptaS. DebnathA. SahaA. GiriB. TripathiG. VedasiromoniJ.R. GomesA. GomesA. Indian black scorpion (Heterometrus bengalensis Koch) venom induced antiproliferative and apoptogenic activity against human leukemic cell lines U937 and K562.Leuk. Res.200731681782510.1016/j.leukres.2006.06.00416876244
     [Google Scholar]
  166. Daniele-SilvaA. MachadoR.J.A. MonteiroN.K.V. EstrelaA.B. SantosE.C.G. CarvalhoE. Araújo JúniorR.F. Melo-SilveiraR.F. RochaH.A.O. Silva-JúniorA.A. Fernandes-PedrosaM.F. Stigmurin and TsAP-2 from Tityus stigmurus scorpion venom: Assessment of structure and therapeutic potential in experimental sepsis.Toxicon2016121102110.1016/j.toxicon.2016.08.01627567704
     [Google Scholar]
  167. KrayemN. Abdelkefi-KoubaaZ. MarrakchiN. GargouriY. LuisJ. Native and recombinant phospholipases A2 of Scorpio maurus venom glands impair angiogenesis by targeting integrins α5β1 and αvβ3.Int. J. Biol. Macromol.201811630531510.1016/j.ijbiomac.2018.04.14129715557
     [Google Scholar]
  168. GuoR. LiuJ. ChaiJ. GaoY. Abdel-RahmanM.A. XuX. Scorpion peptide Smp24 exhibits a potent antitumor effect on human lung cancer cells by damaging the membrane and cytoskeleton in vivo and in vitro .Toxins202214743810.3390/toxins1407043835878176
     [Google Scholar]
  169. SongX. ZhangG. SunA. GuoJ. TianZ. WangH. LiuY. Scorpion venom component III inhibits cell proliferation by modulating NF-κB activation in human leukemia cells.Exp. Ther. Med.20124114615010.3892/etm.2012.54823060939
     [Google Scholar]
  170. SalamaW. SalehA. MostafaM. Optimizing the therapeutic dose of Leiurus quinquestratus scorpion venom in type-2 diabetic mellitus rats.Biological and Biomedical Journal20242213214710.21608/bbj.2024.273446.1021
     [Google Scholar]
  171. NosouhianM. RastegariA.A. ShahanipourK. AhadiA.M. SajjadiehM.S. Anticancer potentiality of Hottentotta saulcyi scorpion curd venom against breast cancer: An in vitro and in vivo study.Sci. Rep.20241412460710.1038/s41598‑024‑75183‑w39427017
     [Google Scholar]
  172. CatterallW.A. Structure and function of voltage-gated sodium channels at atomic resolution.Exp. Physiol.2014991355110.1113/expphysiol.2013.07196924097157
     [Google Scholar]
/content/journals/cdt/10.2174/0113894501396738250904071722
Loading
Therapeutic Potential of Scorpion Venom Proteins: Innovations in Cancer Treatment and Future Directions
Curr Drug Targets 27, 33 (2026); https://doi.org/10.2174/0113894501396738250904071722
/content/journals/cdt/10.2174/0113894501396738250904071722
/content/journals/cdt/10.2174/0113894501396738250904071722
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): Apoptosis; bioactive peptide; cancer therapy; immunomodulation; scorpion venom; toxin

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test